496 results on '"Nakai, Hisao"'
Search Results
2. Construction of an evacuee placement model for tsunami shelters considering physical distancing to prevent COVID-19 infection
3. Turnover Intention among Staff Who Support Older Adults Living Alone in Japan: A Cross-Sectional Study.
4. Factors related to Japanese nurses’ desire to quit their jobs during the COVID-19 pandemic: A cross-sectional study
5. Effect of the 2024 Noto Peninsula earthquake on outpatient chemotherapy among cancer survivors in Japan: a retrospective study.
6. Factors Related to the Willingness of People with Mental Health Illnesses Living in Group Homes to Disclose Their Illness to Supporters during Disaster Evacuation: A Cross-Sectional Study.
7. Factors Associated with Turnover Intentions of Nurses Working in Japanese Hospitals Admitting COVID-19 Patients
8. Factors Related to Evacuation Intentions of Power-Dependent Home Care Patients in Japan
9. 日本のケアマネジャーにおける認知症の行動・心理症状のケアマネジメントに影響を与える要因
10. Caregiver Burden among Family Caregivers of Cancer Survivors Aged 75 Years or Older in Japan: A Pilot Study
11. Understanding Mothers’ Worries about the Effects of Disaster Evacuation on Their Children: A Cross-Sectional Study
12. Factors Related to Care Managers’ Experiences of Making Proxy Decisions about Older Adults Living Alone: A Cross-Sectional Study
13. Evaluation of Everyday Living Areas for Deinstitutionalized Community-Living People with Mental Illness.
14. Disaster Evacuation for Home-Based Patients with Special Healthcare Needs: A Cross-Sectional Study
15. Childcare Center Evacuation to Vertical Shelters in a Nankai Trough Tsunami: Models to Predict and Mitigate Risk
16. Correlation between Quality of Life under Treatment and Current Life Satisfaction among Cancer Survivors Aged 75 Years and Older Receiving Outpatient Chemotherapy in Ishikawa Prefecture, Japan
17. Catheter blockage factors in patients cared for in their own home requiring long‐term urinary catheterisation
18. Synthesis and evaluation of γ-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists
19. Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists
20. Synthesis and evaluation of novel modified γ-lactam prostanoids as EP4 subtype-selective agonists
21. Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF1) receptor antagonists
22. Community-Based Integrated Care System for People with Mental Illness in Japan: Evaluating Location Characteristics of Group Homes to Determine the Feasibility of Daily Life Skill Training
23. Application Software That Can Prepare for Disasters Based on Patient-Participatory Evidence: K-DiPS: A Verification Report
24. Factors related to preparedness for emergency hemodialysis in the event of a natural disaster
25. Discovery of new orally active prostaglandin D2 receptor antagonists
26. Design and synthesis of new prostaglandin D2 receptor antagonists
27. 6,7-Dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives as novel corticotropin-releasing factor 1 receptor antagonists
28. Pyrazolo[1,5- a]pyrimidines, triazolo[1,5- a]pyrimidines and their tricyclic derivatives as corticotropin-releasing factor 1 (CRF 1) receptor antagonists
29. Discovery of selective indole-based prostaglandin D 2 receptor antagonist
30. Discovery of 4-[4-({(3 R)-1-butyl-3-[( R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid hydrochloride: A highly potent orally available CCR5 selective antagonist
31. Factors Affecting Nurses’ Internal Transfer Intentions after the Introduction of COVID-19-Related Family Visiting Restrictions
32. Discovery of orally available spirodiketopiperazine-based CCR5 antagonists
33. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs
34. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 2: Optimization of the side chains to improve in vitro and in vivo potencies
35. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 1: Discovery and exploration of the carboxyamide side chain
36. Efficacy of the ‘Long-term Urinary Catheter Management Training Program’: a pilot study
37. Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists
38. Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group
39. Discovery of long-acting N-(cyanomethyl)- N-alkyl- l-prolinamide inhibitors of dipeptidyl peptidase IV
40. Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration
41. Design and synthesis of long-acting inhibitors of dipeptidyl peptidase IV
42. Disaster evacuation intentions of persons with mental health problems receiving employment support in Japan
43. Model Comparisons of the Cost Effectiveness of Rubella Vaccination Method in Japanese Adults
44. Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists
45. Discovery of heteroaryl sulfonamides as new EP1 receptor selective antagonists
46. Further optimization of sulfonamide analogs as EP1 receptor antagonists: Synthesis and evaluation of bioisosteres for the carboxylic acid group
47. Design and synthesis of an orally active matrix metalloproteinase inhibitor
48. Discovery of new chemical leads for selective EP1 receptor antagonists
49. Design and synthesis of novel metalloproteinase inhibitors
50. Discovery of a new chemical lead for a matrix metalloproteinase inhibitor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.